T. Rowe PriceStock MarketsUS health care sector: rising demand wit...In addition to the uncertainty triggered by the US government with serious changes at the FDA and other healthcare institutions and an unclear stance of the US Secretary of Health and Human Services … more ➔
European Biosolutions CoalitionBiotech industryAccelerating Europe’s Biotech Revolutio...As the global race for biosolutions intensifies, Europe is at a critical crossroads, and I am deeply concerned about the future of our continent’s biotech industry. While countries like China and the … more ➔
Jeremy Levin, Ovid TherapeuticsStatementAmerica’s Drug Price Revolution: A Boon...On May 12, 2025, President Donald Trump signed an executive order aiming to drastically reduce U.S. prescription drug prices by aligning them with the lowest prices paid in other developed nations—a … more ➔
BRAIN Biotech AGBioeconomyKnowledge-based bioeonomy – reloadedBiotechnology provides the necessary toolbox, ranging from energy-saving biocatalysts for the chemical industry to climate-friendly production of animal feed and food proteins for more resilience, microbial … more ➔
ESTHER NEUMAN MUNICH GERMANYStock MarketsEuropean biotechs navigating a new finan...After the exuberance during the Covid-boost and the post-Covid hangover, 2024 was a rather calm year for the biotechnology sector. This provides an opportunity to take a step back and assess some emerging … more ➔
Sphene CapitalStock MarketsTrump’s win will affect the biotec...During the conference calls on the latest quarterly reports, several recurring questions emerged: What consequences do you anticipate if Trump is to be re-elected? How will tariffs affect supply chains … more ➔
Curie.bioAntibodiesThe golden age of engineered therapeutic...Therapeutic antibodies today represent a cornerstone of the treatment of various diseases including cancer, infectious, autoimmune, cardiovascular, haematological, metabolic, neurologic and ocular diseases, … more ➔
Analyst commentWhere has the conviction gone?2023 was another particularly tumultuous year for life sciences and, although the lingering effects of the last year are unlikely to change dramatically, the stabilisation of interest rates (off 16-year … more ➔
StatementThe future of health biotech innovation... The 2023 State of the Union speech saw biotechnology rise as a priority for the European Union. It has been designated as a critical technology for Europe’s economic security. In March 2024, the European … more ➔
Clinical trialsSMEs suffer from CTISBorn with the aim of harmonising the application, evaluation, and supervision process of clinical trials conducted in EU countries, there is much room for improvement for the Clinical Trial Information … more ➔
T. Rowe Price
European Biosolutions Coalition
Jeremy Levin, Ovid Therapeutics
BRAIN Biotech AG
ESTHER NEUMAN MUNICH GERMANY
Sphene Capital
Curie.bio
